2639 Results

People

  1. Zelenetz
    Zelenetz
  2. Horwitz
    Horwitz
  3. Palomba
    Palomba
  4. Noy
    Noy
  5. Moskowitz
    Moskowitz
  6. Younes
    Younes
  7. Matasar
    Matasar
  8. Moskowitz
    Moskowitz
  9. Yahalom
    Yahalom
  10. Portlock
    Portlock

Groups

  1. Center for Hematologic Malignancies (2639)
  2. Department of Medicine (2639)
  3. Hematologic Malignancies, Division of (2639)
  4. Lymphoma (2639)
  5. Population Sciences Research Program (720)
  6. Survivorship Research (633)
  7. Executive Committee, Center for Hematologic Malignancies (389)
  8. Epidemiology and Biostatistics (363)
  9. GSK Faculty (356)
  10. Department of Pathology and Laboratory Medicine (300)
  1. "Lymphoma"
Formats
  1. Meeting Abstract (1340)
  2. Journal Article (1048)
  3. Book Section (63)
  4. Review (63)
  5. Editorial (37)
  6. Research Letter (35)
  7. Guidelines (18)
  8. Conference Paper (15)
  9. Correspondence (11)
  10. Miscellaneous (5)
  11. Book Whole (4)
Groups
  1. Center for Hematologic Malignancies (2639)
  2. Department of Medicine (2639)
  3. Hematologic Malignancies, Division of (2639)
  4. Lymphoma (2639)
  5. Population Sciences Research Program (720)
  6. Survivorship Research (633)

More Groups

People
  1. Andrew Zelenetz (767)
  2. Steven Horwitz (645)
  3. Maria Palomba (415)
  4. David Straus (356)
  5. Ariela Noy (351)
  6. Alison Moskowitz (339)

More People

Years
  1. 2025 (28)
  2. 2024 (100)
  3. 2023 (180)
  4. 2022 (170)
  5. 2021 (171)
  6. 2020 (170)

More Years

Publications
  1. Blood (833)
  2. Journal of Clinical Oncology (274)
  3. Hematological Oncology (110)
  4. Leukemia and Lymphoma (81)
  5. British Journal of Haematology (79)
  6. Haematologica (71)

More Publications

Publishers
  1. American Society of Hematology (898)
  2. American Society of Clinical Oncology (290)
  3. Elsevier Inc. (187)
  4. Wiley Blackwell (173)
  5. John Wiley & Sons (95)
  6. Nature Publishing Group (92)

More Publishers

Results (2639)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • CHOP and rituximab in elderly patients
    Journal Article

    Portlock, C. S.
    Current Oncology Reports (2002)

    Fulltext@MSK | Save
  • Stanford V and radiotherapy for Hodgkin's disease
    Journal Article

    Portlock, C. S.
    Current Oncology Reports (2002)

    Fulltext@MSK | Save
  • Rituximab for aggressive non-Hodgkin's lymphomas relapsing after or refractory to autologous stem cell transplantation
    Journal Article

    Pan, D.; Moskowitz, C. H.; Zelenetz, A. D.; Straus, D.; Kewalaramani, T.; Noy, A.; Qin, J.; Teruya-Feldstein, J.; Portlock, C. S.
    The Cancer Journal (2002)

    Fulltext@MSK | Save
  • Impact of early response to sequential high-dose chemotherapy on outcome of patients with advanced myeloma and poor prognostic features
    Journal Article

    Niesvizky, R.; Siegel, D.; Glassman, J.; Straus, D.; Fine, J.; Lyons, L.; Michaeli, J.
    Leukemia and Lymphoma (2002)

    Fulltext@MSK | Save
  • Spectral karyotyping identifies new rearrangements, translocations, and clinical associations in diffuse large B-cell lymphoma
    Journal Article

    Nanjangud, G.; Rao, P. H.; Hegde, A.; Teruya-Feldstein, J.; Donnelly, G.; Qin, J.; Jhanwar, S. C.; Zelenetz, A. D.; Chaganti, R. S. K.
    Blood (2002)

    Fulltext@MSK | Save
  • The clinical course of nonsmall cell lung carcinoma in survivors of Hodgkin disease
    Journal Article

    Laurie, S. A.; Kris, M. G.; Portlock, C. S.; Rosenzweig, K. E.; Miller, V. A.; Krug, L. M.; Rusch, V. W.
    Cancer (2002)

    Fulltext@MSK | Save
  • Molecular cytogenetic analysis of genomic instability at the 1q12-22 chromosomal site in B-cell non-Hodgkin lymphoma
    Journal Article

    Itoyama, T.; Nanjangud, G.; Chen, W.; Dyomin, V. G.; Teruya-Feldstein, J.; Jhanwar, S. C.; Zelenetz, A. D.; Chaganti, R. S. K.
    Genes Chromosomes and Cancer (2002)

    Fulltext@MSK | Save
  • Hodgkin's disease
    Book Section

    Yahalom, J.; Straus, D.
    In Pazdur, R.; Coia, L. R.; Hoskins, W. J.; Wagman, L. D. (Eds.) Cancer Management: A Multidisciplinary Approach. 5th ed (2001)

    Fulltext@MSK | Save
  • Dosimetry optimizes tumor dose & enhances safety in non-hodgkins lymphoma patients [PTS] treated with I-131 tositumomab [Bexxar ™]
    Meeting Abstract

    Goldsmith, S. J.; Kaminski, M.; Wahl, R.; Vose, J.; Zelenetz, A.; Kroll, S.; Clapp, K.; Leonard, J. L.; Presbyterian, N. Y.
    Journal of Nuclear Medicine (2001)

    Fulltext@MSK | Save
  • Results of a randomized study of Bexxar (TM) (tositumomab and iodine I 131 tositumomab) vs. unlabeled tositumomab in patients with relapsed or refractory low-grade or transformed non-Hodgkin's lymphoma (NHL)
    Meeting Abstract

    Davis, T. A.; Kaminski, M. S.; Leonard, J. P.; Gregory, S. A.; Wahl, R.; Hsu, F. J.; Wilkinson, M.; Frankel, S. R.; Serafini, A.; Zelenetz, A. D.; more...
    Blood (2001)

    Fulltext@MSK | Save